Partner Article
Salford-based BioClinics gets green light to expand testing
Salford testing firm BioClinics is set for further growth after securing approval to supply its services to several key target markets.
BioClinics conducts its tests by collecting and analysing urine and breath samples. It operates a network of clinics and mobile sample collectors across the UK and Ireland.
The firm has gained accreditations from Achilles Group, which evaluates suppliers on behalf of companies and organisations operating in nearly a dozen sectors.
BioClinics has passed industry audits for its workplace drug and alcohol tests in the transport, rail and utilities sectors.
The accreditations mean BioClinics is now an approved supplier of pre-employment and random tests to the rail and transport sectors, including Network Rail and its sub-contractors, and to utility companies including National Grid and its sub-contractors.
BioClinics experiencing a 470% rise in the number of annual tests it carried out between 2010 and 2013.
Nichola McChrystal, founder and scientific director of BioClinics, said: “We are aiming to double the number of tests we carry out over the next six months. In the longer term, major investment projects such as the HS2 and HS3 rail links should generate even greater demand for our testing services.”
This was posted in Bdaily's Members' News section by Sophia Taha .
The North East investment story needs two engines
We must forge change to close the skills gap
Creating the conditions for North East talent to thrive
Time to end London monopoly on arts talent
Why local government is key to devolution success
Your reputation is worth more than that invoice
There is no perfect time when selling a business
What next when social media career help goes?
The psychological contract that nobody signs
Time for strategy built on the foundational economy
Why being ‘work-ready’ matters more than ever
The North's future doesn't end at Manchester